Prof. Dr. Kayser Çağlar

Hakkında

Özgeçmiş

Mesleki çalışmalarımı Nefroloji ve İç Hastalıkları (Dahiliye) alanlarında sürdürüyorum. Halen Memorial Ankara Hastanesi bünyesinde hasta kabul ediyorum.

Eğitim ve deneyim

Eğitim

• 1980 - 1986, Ankara/Türkiye GATA Hastanesi

Deneyim

• 2025 - Halen, Ankara/Türkiye Memorial Ankara Hastanesi Nefroloji Uzmanı
• 2016 - 2025, Ankara/Türkiye Lösante Hastanesi Nefroloji Uzmanı
• 2013 - 2016, Ankara/Türkiye Memorial Ankara Hastanesi Nefroloji Uzmanı
• 2000 - 2001, Nashville/ABD Vanderbilt Universiyt Nefroloji Uzmanı
• 1995 - 2013, Ankara/Türkiye GATA Hastanesi Nefroloji Asistanlık / Uzmanlık / Öğretim Üyeliği
• 1993 - 1995, Ağrı/Türkiye Ağrı Askeri Hastanesi İç Hastalıkları Uzmanı
• 1989 - 1993, Ankara/Türkiye GATA Hastanesi İç Hastalıklar İç hastalıkları Uzmanı
• 1987 - 1989, KKTC/KKTC KKTC Pratisyen Dr.

Mesleki üyelikler

• Türk Nefroloji Derneği
• Türk Hipertansiyon ve Böbrek Hastalıklar Derrneği
• European Renal Association Üyeliği

Bilimsel yayınlar

• 1: Solak Y, Yilmaz MI, Saglam M, Caglar K, Verim S, Unal HU, Gok M, Demirkaya E, Gaipov A, Kayrak M, Cetinkaya H, Eyileten T, Turk S, Vural A. Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease. Am J Med Sci. 2014 Feb;347(2):118-24. doi: 10.1097/MAJ.0b013e3182996a96. PMID: 23928544.
• 2: Solak Y, Yilmaz MI, Saglam M, Demirbas S, Verim S, Unal HU, Gaipov A, Oguz Y,
• Kayrak M, Caglar K, Vural A, Turk S, Covic A, Kanbay M. Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease. Nephrology (Carlton). 2013 Nov;18(11):728-35. doi: 10.1111/nep.12130. PMID: 23848392.
• 3: Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Turker T, Unal HU, Gok M,
• Cetinkaya H, Eyileten T, Oguz Y, Caglar K, Vural A, Mallamaci F, Zoccali C. Longitudinal analysis of vascular function and biomarkers of metabolic bone disorders before and after renal transplantation. Am J Nephrol. 2013;37(2):126-34. doi: 10.1159/000346711. Epub 2013 Jan 31. PMID: 23391995.
• 4: Solak Y, Yilmaz MI, Sonmez A, Saglam M, Cakir E, Unal HU, Gok M, Caglar K,
• Oguz Y, Yenicesu M, Karaman M, Ay SA, Gaipov A, Turk S, Vural A, Carrero JJ. Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease. Clin Exp Nephrol. 2013 Aug;17(4):532-40. doi: 10.1007/s10157-012-0728-x. Epub 2012 Nov 20. PMID: 23180042.
• 5: Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, Unal HU, Arslan E,
• Verim S, Madero M, Caglar K, Oguz Y, McFann K, Johnson RJ. Serum uric acid
• independently predicts cardiovascular events in advanced nephropathy. Am J Nephrol. 2012;36(4):324-31. doi: 10.1159/000342390. Epub 2012 Sep 22. PMID: 23007099.
• 6: Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, Gok M, Caglar K,
• Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T, Acikel C, Vural A, Covic A. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol. 2012;36(3):228-37. doi: 10.1159/000341868. Epub 2012 Aug 30. PMID: 22948239.
• 7: Kanbay M, Yilmaz MI, Afsar B, Saglam M, Akgul EO, Cayci T, Caglar K, Unal HU,
• Gok M, Vural A, Covic A. Serum calcitonin and endothelial dysfunction in chronic kidney disease: a novel risk factor? Int Urol Nephrol. 2013 Feb;45(1):151-6. doi: 10.1007/s11255-012-0158-4. Epub 2012 Mar 23. PMID: 22437807.
• 8: Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz
• Y, Vural A, Yenicesu M, Mallamaci F, Zoccali C. Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial. Am J Kidney Dis. 2012 Feb;59(2):177-85. doi: 10.1053/j.ajkd.2011.11.007. Epub 2011 Dec 2. PMID: 22137672.
• 9: Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, Eyileten T,
• Caglar K, Oguz Y, Taslipinar A, Vural A, Gok M, Unal HU, Yenicesu M, Carrero JJ. Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease. Clin J Am Soc Nephrol. 2011
• Jul;6(7):1617-25. doi: 10.2215/CJN.10681210. Epub 2011 Jun 23. PMID: 21700826.
• 10: Yilmaz MI, Stenvinkel P, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T,
• Caglar K, Oguz Y, Vural A, Çakar M, Altun B, Yenicesu M, Carrero JJ. Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes. Nephrol Dial Transplant. 2011 Nov;26(11):3537-43. doi: 10.1093/ndt/gfr081. Epub 2011 Mar 4. PMID: 21378154.
• 11: Yilmaz MI, Sonmez A, Ortiz A, Saglam M, Kilic S, Eyileten T, Caglar K, Oguz
• Y, Vural A, Çakar M, Egido J, Altun B, Yenicesu M, Blanco-Colio LM, Carrero JJ. Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes. Clin J Am Soc Nephrol. 2011 Apr;6(4):785-92. doi: 10.2215/CJN.09231010. Epub 2011 Feb 17. PMID: 21330486; PMCID: PMC3069370.
• 12: Yilmaz MI, Sonmez A, Karaman M, Ay SA, Saglam M, Yaman H, Kilic S, Eyileten
• T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C. Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease. Am J Nephrol. 2011;33(1):25-32. doi: 10.1159/000322581. Epub 2010 Dec 9. PMID: 21150192.
• 13: Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E, Eyileten T,
• Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int.
• 2010 Oct;78(7):679-85. doi: 10.1038/ki.2010.194. Epub 2010 Jul 7. PMID: 20613714.
• 14: Eyileten T, Sonmez A, Saglam M, Cakir E, Caglar K, Oguz Y, Vural A, Yenicesu
• M, Yilmaz MI. Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy. Nephrology (Carlton). 2010 Mar;15(2):225-9. doi: 10.1111/j.1440-1797.2009.01173.x. PMID: 20470283.
• 15: Afsar B, Afsar RE, Sen ST, Kirkpantur A, Eyileten T, Yilmaz MI, Caglar K.
• Simple renal cysts and circadian blood pressure: are they related to each other in patients with hypertension? Int Urol Nephrol. 2011 Mar;43(1):157-65. doi: 10.1007/s11255-010-9734-7. Epub 2010 Apr 13. PMID: 20390353.
• 16: Yilmaz MI, Sonmez A, Saglam M, Yaman H, Cayci T, Kilic S, Eyileten T, Caglar
• K, Oguz Y, Vural A, Yenicesu M, Axelsson J. Reduced proteinuria using ramipril in diabetic CKD stage 1 decreases circulating cell death receptor activators concurrently with ADMA. A novel pathophysiological pathway? Nephrol Dial Transplant. 2010 Oct;25(10):3250-6. doi: 10.1093/ndt/gfq159. Epub 2010 Mar 26. PMID: 20348148.
• 17: Yilmaz MI, Qureshi AR, Carrero JJ, Saglam M, Suliman ME, Caglar K, Eyileten
• doi: 10.1159/000272936. Epub 2009 Dec 31. PMID: 20068285 T, Sonmez A, Oguz Y, Vural A, Yenicesu M, Axelsson J. Predictors of carotid artery intima-media thickness in chronic kidney disease and kidney transplant patients without overt cardiovascular disease. Am J Nephrol. 2010;31(3):214-21.
• 18: Sonmez A, Yilmaz MI, Saglam M, Kilic S, Eyileten T, Uckaya G, Caglar K, Oguz
• Y, Vural A, Yenicesu M, Kutlu M, Kinalp C, Zoccali C. The relationship between hemoglobin levels and endothelial functions in diabetes mellitus. Clin J Am Soc Nephrol. 2010 Jan;5(1):45-50. doi: 10.2215/CJN.05080709. Epub 2009 Oct 15. PMID: 19833907; PMCID: PMC2801645.
• 19: Afsar B, Elsurer R, Eyileten T, Yilmaz MI, Caglar K. Antibody response
• following hepatitis B vaccination in dialysis patients: does depression and life quality matter? Vaccine. 2009 Sep 25;27(42):5865-9. doi: 10.1016/j.vaccine.2009.07.055. Epub 2009 Aug 3. PMID: 19654067.

Konuşulan diller

Çalışma yerleri 1